Intra-abdominal pressure ("IPP") measurement method, device, and system

JP2023549676A5Active Publication Date: 2024-11-13VANTIVE US HEALTHCARE LLC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023526009
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-04
Filing Date
2021-11-03
Publication Date
2024-11-13
Estimated Expiration
2041-11-03

AI Technical Summary

Technical Problem

Current methods for measuring intraperitoneal pressure (IPP) in peritoneal dialysis are inaccurate due to low sensitivity of pressure sensors, movement artifacts, and influences from patient factors such as food intake and fluid balance, leading to suboptimal fill volume parameters.

Method used

The use of pressure amplifiers, force sensors, spirometers, and processors to enhance IPP measurement accuracy by compensating for sensor and patient movement, integrating with peritoneal dialysis systems to adjust fill volume parameters based on lung volume and patient data.

Benefits of technology

Improves IPP measurement precision, allowing for more accurate determination of fill volume parameters, reducing patient discomfort and treatment inefficiencies by accounting for patient-specific factors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2022098714000001
    Figure 2022098714000001
  • Figure 2022098714000002
    Figure 2022098714000002
  • Figure 2022098714000003
    Figure 2022098714000003
Patent Text Reader

Abstract

An intraperitoneal pressure ("IPP") measurement device is disclosed herein. In one embodiment, the IPP measurement device includes a transferset or catheter fluidly coupled to a patient's abdominal cavity and a pressure sensor adapted to contact the transferset or catheter. The pressure sensor is configured to transmit output data indicative of IPP within the patient's abdominal cavity. The pressure sensor includes a pressure element configured to measure pressure exerted by fluid in the transferset or catheter. The pressure sensor also includes a pressure amplifier having a first side contacting a portion of the transferset or catheter and a second side contacting the pressure element. The first side has a larger diameter or surface area compared to the second side to amplify the pressure signal for IPP measurement.
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] Due to various causes, the human renal system may fail. Renal failure results in several physiological disorders. For example, a person with renal failure can no longer maintain water and mineral balance or excrete daily metabolic loads. In addition, toxic end products of metabolism, such as urea, creatinine, uric acid, and others, can accumulate in the patient's blood and tissues.

[0002]

[0003] Reduced kidney function, particularly kidney failure, is treated using dialysis. Dialysis removes waste products, toxins, and excess water from the body that normally functioning kidneys would otherwise remove. Dialysis treatment for kidney function replacement is important for many people because the treatment can be lifesaving.

[0003] One type of kidney failure therapy is peritoneal dialysis ("PD"), in which a dialysate, also called dialysis fluid or PD fluid, is infused into a patient's peritoneal cavity via a catheter. The dialysis fluid contacts the peritoneal membrane within the patient's peritoneal cavity. Waste, toxins, and excess water pass from the patient's bloodstream through capillaries in the peritoneal membrane into the dialysis fluid due to diffusion and osmosis (i.e., an osmotic gradient across the membrane). Osmotic agents in the dialysis fluid provide the osmotic gradient. Spent or spent dialysis fluid is drained from the patient, removing the waste, toxins, and excess water from the patient. This cycle is repeated multiple times for the patient.

[0004] Various types of peritoneal dialysis therapies exist, including continuous ambulatory peritoneal dialysis ("CAPD"), automated peritoneal dialysis ("APD"), tidal flow dialysis, and continuous flow peritoneal dialysis ("CFPD"). CAPD is a manual dialysis treatment. Here, a patient manually connects an implanted catheter to a drain line, allowing used or spent dialysis fluid to drain from the peritoneal cavity. The patient then switches the fluid connection so that the patient catheter is in communication with a bag of fresh dialysis fluid and infuses fresh dialysis fluid through the catheter and into the patient. The patient disconnects the catheter from the fresh dialysis fluid bag, allowing the dialysis fluid to dwell in the peritoneal cavity, where transfer of waste products, toxins, and excess water occurs. After the dwell period, the patient repeats the manual dialysis procedure, for example, four times per day. Manual peritoneal dialysis requires a significant amount of time and effort from the patient and leaves significant room for improvement.

[0005] Automated peritoneal dialysis ("APD") is similar to CAPD in that dialysis therapy includes a drain cycle, a fill cycle, and a dwell cycle. However, APD machines typically perform the cycles automatically while the patient sleeps. APD machines relieve patients of the need to manually perform treatment cycles and to carry consumables during the day. APD machines fluidly connect an implanted catheter to a source of fresh dialysis fluid or its bag and a fluid drain. The APD machine pumps fresh dialysis fluid from the dialysis fluid source through the catheter and into the patient's peritoneal cavity. APD machines also allow the dialysis fluid to dwell in a chamber, allowing transfer of waste, toxins, and excess water to occur. The source may contain several liters of dialysis fluid, including several solution bags.

[0006] APD machines pump used or spent dialysate from the patient's peritoneal cavity through a catheter to a drain. As with manual processes, several drain, fill, and dwell cycles occur during dialysis. A "final fill" may occur at the end of an APD treatment. The final fill fluid may remain in the patient's peritoneal cavity until the start of the next treatment, or it may be manually emptied at some point during the day.

[0007] In many cases, a clinician determines certain parameters that define how PD therapy should be administered. For example, the clinician may define a fill volume parameter, which defines the amount of dialysis fluid to be provided into the patient's peritoneal cavity during the fill phase of a therapy cycle. The clinician may also define a drain parameter, which defines the amount of spent or used dialysate (and ultrafiltrate) to be collected during drain. The clinician may also define a dwell parameter, which defines the duration the dialysis fluid will remain in the patient's peritoneal cavity. For many therapies, the clinician may also prescribe a concentration of glucose for the dialysis fluid to achieve certain therapeutic goals.

[0008] While all of the above parameters are important for PD treatment, the fill volume parameter can be crucial. If the fill volume parameter is too high, the patient may become overfilled during treatment, leading to discomfort. If the fill volume parameter is too low, PD treatment may be less effective at removing accumulated toxins. Currently, many clinicians estimate the fill volume parameter using measurements of the patient's intra-abdominal pressure ("IPP"), which is a measure of the pressure within the patient's abdominal cavity as a result of accumulated fluid and waste products. Generally, a patient's IPP increases as fluid volume increases. Fill volume can be determined as the amount of PD fluid delivered to the patient's abdominal cavity that causes the pressure to reach a certain clinically acceptable threshold, generally 15-20 centimeters of water ("cmH2O") (0.213-0.284 pounds per square inch ("psig"). In some cases, the patient's abdominal cavity volume is estimated using the patient's height, age, and sex compared to population averages for similar individuals. The estimated volume may then be adjusted based on the measured IPP to determine a fill volume parameter for PD therapy.

[0009] For various reasons, IPP measurements may not be very accurate. Relatively low peritoneal pressure makes IPP measurement particularly challenging, as many pressure sensors provide more accurate measurements above 1.0 psig, which may exceed some IPP ranges. In some cases, the patient or measurement equipment may move during measurement, which affects the IPP measurement. Even slight movement can cause IPP measurements to fluctuate by 20-30%. Additionally, a patient's food and beverage intake within 24 hours leading up to the measurement can affect IPP measurement results.

[0010] Therefore, a need exists for improved IPP measurement systems and methods. Summary of the Invention [Means for solving the problem]

[0011] Disclosed herein are exemplary systems, methods, and devices for improved intraperitoneal pressure ("IPP") measurement or estimation. In some embodiments, the systems, methods, and devices include a pressure amplifier with a pressure sensor connected to or otherwise integrated with a transferset or catheter. The exemplary pressure amplifier includes a first side that contacts the transferset or catheter and a second side that contacts a pressure sensor element. The first side has a smaller diameter compared to the second side. Pressure exerted on the first side of the amplifier by PD fluid located within the transferset or catheter is magnified in magnitude based on Pascal's law, exerting a proportionally greater force on the pressure sensor element. In alternative embodiments, pressure amplification can occur using a different material with higher elasticity than the rest of the transferset or catheter. Regions with higher elasticity exert proportionally greater pressure on the sensor element. Improved pressure measurements allow clinicians to determine the appropriate fill volume parameters for the patient.

[0012] Additionally or alternatively, in some embodiments, the systems, methods, and devices disclosed herein include a force sensor provided within the pressure sensor housing to measure IPP. The force sensor may include at least one of an inertial sensor, a gyroscope, and / or an accelerometer for sensing at least one of linear and / or rotational acceleration in one or more axes. The force sensor provides an indication of patient and / or pressure sensor movement during IPP measurement. Data output from the force sensor is used to normalize or adjust the IPP measurement data to compensate for any detected patient and / or pressure sensor movement that would otherwise affect the IPP measurement results.

[0013] Additionally or alternatively, in some embodiments, the systems, methods, and devices disclosed herein include a spirometer for measuring IPP pressure. The spirometer records the patient's lung volume as additional amounts of PD fluid are delivered to the patient's abdominal cavity. The correlation between the patient's lung volume and IPP for different filling volumes allows a clinician to determine filling volume parameters using the measured lung volumes. In some cases, the spirometer is used in conjunction with a pressure sensor to provide a more accurate estimate of the IPP and / or filling volume parameters. In other cases, the spirometer is used in place of a pressure sensor to estimate the patient's IPP for determining filling volume parameters related to PD treatment.

[0014] Additionally or alternatively, in some embodiments, the systems, methods, and devices disclosed herein include a processor that performs a comparison of one or more ranges of IPP measurements and pressure data to determine whether the catheter and / or transfer set is partially blocked or misaligned. During the filling of PD fluid into the patient's abdominal cavity, the detected pressure is compared to one or more ranges. Detection of IPP data within a certain range may cause an alarm to be provided, prompting the clinician to check the catheter or transfer set. In some cases, IPP measurement data is not received until the IPP measurement data during the PD fluid fill is within an acceptable range. Furthermore, the processor may be configured to compare the measured IPP data with one or more acceptable ranges to confirm that the IPP measurement corresponds to a dwell rather than a PD fluid fill.

[0015] Additionally or alternatively, in some embodiments, the systems, methods, and devices disclosed herein include a processor that receives patient information indicating the patient's urine output, food / drink intake, heart rate, and / or blood pressure. The patient information may correspond to periods before, during, and / or after the IPP measurement. The processor is configured to use the patient information to adjust the fill volume parameter so that the parameter is not based solely on the IPP measurement. The patient information includes factors that may affect the IPP measurement. For example, a high level of beverage consumption accompanied by a low urine output may indicate that the patient is edematous or retaining water, which may cause the IPP measurement to be larger than if the patient had a more normal fluid balance. Considering these factors allows a more accurate fill volume to be determined for the patient.

[0016] In a first aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein in light of the present disclosure as set forth herein and without limiting the present disclosure in any way, an intraperitoneal pressure ("IPP") measurement device includes a transfer set or catheter fluidly coupled to a patient's abdominal cavity and a pressure sensor configured to contact the transfer set or catheter. The pressure sensor is configured to transmit output data indicative of the IPP in the patient's abdominal cavity. The pressure sensor includes a pressure element configured to measure pressure exerted by fluid in the transfer set or catheter, and a pressure amplifier having a first side contacting a portion of the transfer set or catheter and a second side contacting the pressure element. The first side has a larger diameter or surface area compared to the second side.

[0017] In a second aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the first side includes a diameter or surface area that is at least twice the diameter or surface area of ​​the second side, providing pressure amplification by at least a factor of two.

[0018] In a third aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the pressure element includes at least one of a piezoresistive strain gauge, a pressure-sensing diaphragm, a capacitive diaphragm, a pressure-sensing capsule, or a Bourdon tube.

[0019] In a fourth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the pressure sensor is integrally formed with the transfer set or catheter.

[0020] In a fifth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the pressure sensor is mechanically connected to a transfer set or a catheter.

[0021] In a sixth aspect of the present disclosure that may be combined with any other aspect or portion thereof described herein, an intraperitoneal pressure ("IPP") measurement system includes a fluid container containing peritoneal dialysis ("PD") fluid, and a transfer set and catheter in fluid communication with the fluid container and in fluid communication with the patient's peritoneal cavity, configured to allow PD fluid to be provided to the patient's peritoneal cavity. The system also includes a pressure sensor configured to contact the transfer set or catheter. The pressure sensor is configured to transmit output data indicative of the IPP in the patient's peritoneal cavity. The pressure sensor includes a pressure element configured to measure pressure exerted by fluid in the transfer set or catheter, and a pressure amplifier having a first side contacting a portion of the transfer set or catheter and a second side contacting the pressure element. The first side has a larger diameter or surface area compared to the second side. The system further includes a processor communicatively coupled to the pressure sensor. The processor is configured to receive output data indicative of IPP in the patient's abdominal cavity and at least one of use the output data indicative of IPP to determine a fill volume parameter related to PD therapy for the patient, or display the output data indicative of IPP to enable determination of the fill volume parameter.

[0022] In a seventh aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, output data indicative of IPP in the patient's abdominal cavity corresponds to pressure measurements made by a pressure sensor during a dwell interval between when PD fluid is provided to and removed from the patient's abdominal cavity.

[0023] In an eighth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the fluid container is placed at head height, and the system further includes a line clamp that, when closed, occludes the flow of PD fluid through the transfer set or catheter.

[0024] In a ninth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the system further includes a pump configured, when activated, to move PD fluid from the fluid container through the transfer set and catheter to the patient's abdominal cavity.

[0025] In a tenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the system further includes an automated peritoneal dialysis ("APD") machine configured to provide PD therapy for the patient using at least the fill volume parameter.

[0026] In an eleventh aspect of the present disclosure that may be combined with any other aspect or a portion thereof described herein, the system further includes a force sensor included with the pressure sensor or adapted to contact the transfer set or catheter. The force sensor includes at least one of an inertial sensor, a gyroscope, or an accelerometer for sensing at least one of linear or rotational acceleration in one or more axes. The force sensor is configured to output force data indicative of at least one of patient movement or pressure sensor movement.

[0027] In a twelfth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, a processor is configured to receive force data, use the force data, and adjust output data indicative of IPP to account for measurement components related to at least one of patient movement or pressure sensor movement.

[0028] In a thirteenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the processor is configured to compare output data indicative of the IPP with at least one data range, and provide an indication that a problem exists with at least one of the transfer set or the catheter when the comparison is outside the at least one data range, and use the output data indicative of the IPP to determine a fill volume parameter when the comparison is within the at least one data range.

[0029] In a fourteenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the processor is configured to receive second output data from the pressure sensor indicative of the pressure during filling of the patient's abdominal cavity with increasing amounts of PD fluid, compare the second output data indicative of the pressure during filling of the patient's abdominal cavity with a second data range, and provide an indication that there is a problem with at least one of the transfer set or the catheter when the comparison is outside the second data range, and use the output data indicative of the IPP to determine a fill volume parameter when the comparison is within the second data range.

[0030] In a fifteenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, a processor is configured to receive patient information including at least one of urine output within a defined period, food / drink intake within a defined period, heart rate, or blood pressure, and to adjust output data indicative of an IPP or a fill volume parameter using the patient information.

[0031] In a sixteenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the defined period includes at least one of 24 hours or 48 hours prior to causing the pressure sensor to provide output data indicative of the patient's IPP.

[0032] In a seventeenth aspect of the present disclosure that may be combined with any other aspect or portion thereof described herein, an intraperitoneal pressure ("IPP") measurement system includes a fluid container containing peritoneal dialysis ("PD") fluid, and a transfer set and catheter fluidly coupled to the fluid container and the patient's peritoneal cavity to enable the PD fluid to be provided to the patient's peritoneal cavity. The system further includes a spirometer for transmitting output data indicative of the patient's lung volume, and a processor communicatively coupled to the spirometer. The processor is configured to record output data from the spirometer during a dwell interval between when the PD fluid is provided to and removed from the patient's peritoneal cavity, and to use a correlation between lung volume and IPP to determine at least one of the IPP or a filling volume parameter based on at least the output data from the spirometer.

[0033] In an eighteenth aspect of the present disclosure that may be combined with any other aspect or portion thereof described herein, the system further includes a pressure sensor adapted to contact the transfer set or catheter, the pressure sensor configured to transmit second output data indicative of IPP in the patient's abdominal cavity, and the processor configured to determine a fill volume parameter using the output data from the spirometer and the second output data from the pressure sensor.

[0034] In a nineteenth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the fluid container is installed at head height, and the system further includes a line clamp that, when closed, occludes the flow of PD fluid through the transfer set or catheter.

[0035] In a twentieth aspect of the present disclosure, which may be combined with any other aspect or portion thereof described herein, the system further includes a pump configured to move PD fluid from the fluid container through the transfer set and catheter to the patient's abdominal cavity.

[0036] In a twenty-first aspect, any of the features, functionality, and alternatives described in connection with any one or more of Figures 2-15 may be combined with any of the features, functionality, and alternatives described in connection with any other of Figures 2-15.

[0037] In light of the present disclosure and the above aspects, it is therefore an advantage of the present disclosure to provide improved IPP measurement or estimation.

[0038] It is another advantage of the present disclosure to determine more accurate fill volume parameters for PD treatment.

[0039] It is yet another advantage of the present disclosure to provide adjustments to IPP measurements to account for patient factors and / or shifts between IPP measurements.

[0040] Additional features and advantages will be described in, and will be apparent from, the following detailed description and figures. The features and advantages described herein are not all-inclusive; in particular, many additional features and advantages will become apparent to those skilled in the art in light of the figures and description. Moreover, any particular embodiment need not possess all of the advantages enumerated herein; this is expressly contemplated as separately claiming each advantageous embodiment. It should also be noted that the language used herein has been chosen primarily for readability and instructional purposes, and not to limit the scope of the inventive subject matter. [Brief explanation of the drawings]

[0041] [Figure 1] FIG. 1 shows a schematic diagram of a known IPP measurement technique.

[0042] [Figure 2] FIG. 2 is a schematic diagram showing the extent to which the volume of the abdominal cavity changes during inspiration and expiration of breath.

[0043] [Figure 3]3 and 4 are schematic diagrams of an exemplary IPP measurement system according to an exemplary embodiment of the present disclosure. [Figure 4] 3 and 4 are schematic diagrams of an exemplary IPP measurement system according to an exemplary embodiment of the present disclosure.

[0044] [Figure 5] 5-7 are schematic diagrams of the pressure sensor of FIGS. 3 and 4 according to exemplary embodiments of the present disclosure. [Figure 6] 5-7 are schematic diagrams of the pressure sensor of FIGS. 3 and 4 according to exemplary embodiments of the present disclosure. [Figure 7] 5-7 are schematic diagrams of the pressure sensor of FIGS. 3 and 4 according to exemplary embodiments of the present disclosure.

[0045] [Figure 8] FIG. 8 is a diagram illustrating a force sensor connected to or otherwise integrated with the pressure sensor of FIGS. 3-7, according to an exemplary embodiment of the present disclosure.

[0046] [Figure 9] FIG. 9 is a flow diagram of an exemplary procedure for determining a fill volume parameter using force output data in conjunction with IPP measurements, according to an exemplary embodiment of the present disclosure.

[0047] [Figure 10] FIG. 10 is a diagram illustrating how a processor and / or portable device calculates IPP components related to patient and / or sensor movement, according to an exemplary embodiment of the present disclosure.

[0048] [Figure 11] 11 and 12 are schematic diagrams of graphs illustrating a comparison of IPP measurements with one or more ranges and / or thresholds, according to exemplary embodiments of the present disclosure. [Figure 12]11 and 12 are schematic diagrams of graphs illustrating a comparison of IPP measurements with one or more ranges and / or thresholds, according to exemplary embodiments of the present disclosure.

[0049] [Figure 13] FIG. 13 is a diagram illustrating data processing by a processor and / or portable device to adjust IPP measurements based on patient information, according to an exemplary embodiment of the present disclosure.

[0050] [Figure 14] FIG. 14 is a schematic diagram of an exemplary system in which a spirometer is used to perform lung volume measurements for determining fill volume parameters for PD treatment, according to an exemplary embodiment of the present disclosure.

[0051] [Figure 15] FIG. 15 is a schematic illustration of a graph of patient-specific correlation between lung volume and filling volume, according to an exemplary embodiment of the present disclosure. DETAILED DESCRIPTION OF THE INVENTION

[0052] Detailed Description Disclosed herein are methods, systems, and devices for improved intra-abdominal pressure (IPP) measurement or estimation. The methods, systems, and devices provide more accurate IPP measurements and / or filling volume estimates compared to known IPP measurement techniques. As described herein, the methods, systems, and devices include one or more of: (i) providing a sensor amplifier to amplify pressure sensor measurements to match the more sensitive and precise area of ​​the pressure sensor element; (ii) using a force sensor to adjust for pressure sensor and / or patient movement during IPP measurement; (iii) using a spirometer to correlate lung volume with IPP and / or patient filling volume; (iv) using known ranges to validate IPP measurement data; and / or (v) using urine output data, food / beverage consumption data, blood pressure data, and / or heart rate data to adjust IPP measurements and / or filling volume estimates.

[0053] The present disclosure is directed herein to performing IPP measurements to determine fill volume parameters for PD therapy. It should be understood that any of the methods, systems, and devices disclosed herein can also be used to measure IPP during PD therapy. IPP measurements during therapy can be used to stop PD fluid fills when the detected IPP exceeds a threshold, extend PD drainage, and / or change from continuous cyclic peritoneal dialysis ("CCPD") to tidal therapy if the patient's residual volume in the peritoneal cavity exceeds a threshold. In some cases, IPP measurements that exceed a threshold can trigger an alert for the patient and / or be communicated to a clinician.

[0054] 1 shows a schematic diagram of a known IPP measurement technique. The known IPP measurement system 100 includes a transfer set 102 that is fluidly connected to a catheter 104 that is inserted into or fluidly connected to a patient's abdominal cavity 106. Another end (not shown) of the transfer set 102 is connected to a source or container of fluid, such as PD fluid. The IPP measurement system 100 also includes a measurement or drain line 108 that is fluidly connected to the catheter 104 and / or the transfer set 102.

[0055] An IPP measurement provides a measurement of the IPP in a patient's abdominal cavity for a given volume of infused PD fluid. For IPP measurements, the patient is typically in a supine or horizontal position, as shown in FIG. 1. The patient is also relaxed, and their head is supported to allow their abdominal wall to relax. This patient positioning avoids pressure on the abdomen. As shown in FIG. 1, a drainage bag 112 is held within the raised support for the drainage line 108. A graduated ruler or other distance measuring device 114 is placed next to the drainage line 108, running up from the patient to the bag 112, as shown, aligning level 0 (i.e., 0 cm) with the mid-axillary line.

[0056] To perform the measurement, PD fluid is provided from a source through the transfer set 102 and catheter 104 to the patient's abdominal cavity 106. The abdominal cavity 106 is filled to a percentage of the cavity's volume. After the desired amount of PD fluid has been provided to the abdominal cavity 106, the clamp 110 is closed, preventing further fluid flow from the source. The catheter connection is then opened, allowing at least a portion of the PD fluid from the patient's abdominal cavity to flow into the drain line 108. A column of PD fluid rises in the drain line 108 to a stable level using a respiratory oscillation of 1-3 cmH2O, which provides an average measurement. Figure 2 is a schematic diagram illustrating the extent to which the volume of the abdominal cavity changes during inspiration and expiration. As shown in this figure, the IPP during inspiration is larger because the abdominal cavity contracts to a smaller state. The IPP difference between inspiration and expiration is averaged to determine the IPP for the patient. In other words, the IPP is measured as the midpoint of that oscillation and is expressed in centimeters of water ("cmH2O"). Once the measurement is obtained, the abdominal cavity is drained and the volume is recorded as the fill volume in the drain bag 112. This process can be repeated for different amounts of PD fluid to determine the correlation between IPP measurement and fill volume for a particular patient.

[0057] In stable adult PD patients, an IPP of 10–16 cmH2O at the mid-axillary line is generally considered acceptable for PD treatment, corresponding to 1.3–2.8 liters ("L") of infused PD fluid. Interpatient differences between IPP and infused PD fluid volume are due to variations in intraperitoneal volume ("IPV"), body position (with upright patients exhibiting a 2–4 ​​cmH2O increase compared to supine), physical activity, weight, height, and gender. Clinicians typically prefer to keep IPP below 18–20 cmH2O because higher pressures are associated with symptoms such as discomfort, bloating, sleep disturbances, hemodynamic problems, and respiratory modifications. Higher pressures may also contribute to certain mechanical complications (e.g., leaks, hernias).

[0058] IPP measurements can also be taken while the patient is standing or seated. In these cases, point "0" is considered to be in the mid-axillary line at the midpoint between the patient's xiphoid process and pubic symphysis, or in the anterior superior iliac spine. Despite the change in position, IPP measurements are performed in the same manner as described above for the patient in the supine position. I. IPP Measurement Implementation

[0059] 3 and 4 are schematic diagrams of an exemplary IPP measurement system 300 according to an exemplary embodiment of the present disclosure. The exemplary system 300 includes a transfer set 102 having a first end connected to a fluid container 302. The fluid container 302 may include any physiologically compatible fluid source. The fluid container 302 is a PD fluid source and may include a bag or other enclosure configured to hold a volume of fluid, such as 1-2 liters of fluid. In some embodiments, the fluid container 302 contains fresh, pre-made PD fluid with a prescribed glucose concentrate. In some embodiments, the fluid container 302 may include two chambers, one with a dialysis concentrate and the other with purified water. In such embodiments, the container 302 includes a seal that, when ruptured, allows the fluids in the two chambers to mix. The physiologically compatible fluid may include PD fluid, saline, renal replacement fluid, etc.

[0060] A second end of the transferset 102 is connected to a catheter 104, which is fluidly coupled to the patient's abdominal cavity 106. The transferset 102 and / or catheter 104 may be made from any one or more of polyvinyl chloride ("PVC"), polyethylene ("PE"), polyurethane ("PU"), polycarbonate, or other non-PVC materials.

[0061] In some embodiments, the system 300 of FIG. 3 may include a line clamp 110 for selectively restricting the flow of PD fluid through the transfer set 102. The illustrated embodiment may also include a pump 304. The exemplary pump 304 may include a pump head fluidly connected to the transfer set 102. The pump 306 may be any type of fluid pump, such as a peristaltic pump, a gear pump, or a diaphragm pump. The pump head may be disposable and connected to a reusable actuator controlled by an internal or external control unit. The exemplary pump 304 is configured to pump fresh PD fluid from the container 302 to the patient's peritoneal cavity 106 and perform an IPP measurement. The exemplary pump 304 may also pump used PD fluid (including removed toxins and absorbed ultrafiltrate) from the patient's peritoneal cavity 106 back to the container 302 after the IPP measurement is recorded. In alternative embodiments, separate pumps are provided to (i) pump fluid to the patient and (ii) pump or withdraw fluid from the patient. In some embodiments, pump 304 is configured to occlude fluid flow from fluid container 302 until the pump head is actuated, thereby preventing free flow of PD fluid and allowing clamp 110 to be omitted.

[0062] The IPP measurement system 300 of FIG. 3 also includes a pressure sensor 306 for performing IPP measurements. The pressure sensor 306 in the illustrated embodiment is positioned to measure fluid pressure within the transfer set 102. In other embodiments, the pressure sensor 306 may be connected to or comprise the catheter 104. As PD fluid is provided to or removed from the peritoneal cavity 106, the pressure measurements indicate the fluid pressure being brought to or removed from the peritoneal cavity 106. When the pump is stopped and the PD fluid is allowed to dwell in the peritoneal cavity for a defined duration, the pressure measurements provided by the pressure sensor 306 indicate the IPP. The pressure measurements may also be used to detect line blockages (based on upward positive or negative pressure spike waveforms / trends) or fluid leaks (based on downward positive or negative pressure spike waveforms / trends).

[0063] In the illustrated example, pressure sensor 306 is shown as being in line with transferset 102. It should be understood that pressure sensor 306 may be in line with or otherwise integrated with catheter 104. It should also be understood that pressure sensor 306 may include a disposable tubing section that contacts transferset 102 and PD fluid, while the remainder of sensor 306 is reusable between IPP measurements. Alternatively, the entire pressure sensor 306 may be disposable.

[0064] In some embodiments, the system 300 may also include a flow sensor (not shown) having an output integrated to measure the volume of PD fluid provided to and / or removed from the patient. It should be understood that one or more pressure sensors 306 may additionally or alternatively be used to measure the flow rate or flow rate of fluid delivered to or removed from the abdominal cavity 106. Furthermore, the system 300 may include a heater to warm the PD fluid prior to infusion into the patient. The system 300 may further include a temperature sensor to ensure that the PD fluid is heated to a desired temperature.

[0065] Although not shown, an air trap may be provided within the transfer set 102 to remove air from the PD fluid prior to patient delivery. In other cases, priming the transfer set 102 may remove air without the need for an air trap. Heating the dialysis fluid tends to separate dissolved air from the dialysis fluid. Therefore, it is contemplated to place an air trap downstream from the heater, for example, upstream of the temperature sensor along the transfer set 102.

[0066] The exemplary system 300 also includes a processor 310 for communicating with the pressure sensor 306. The processor 310 may include any computer, laptop, workstation, server, etc. In some embodiments, the processor 310 is communicatively coupled to the pressure sensor 306 via a wired interface, such as a Universal Serial Bus ("USB") connection, or a wireless interface, such as a Bluetooth, Zigbee, or near field communication ("NFC") connection. Additionally, the processor 310 may also be communicatively coupled to the pump 304.

[0067] As described herein, the exemplary processor 310 executes machine-readable instructions stored in a memory device. The instructions may include an application or a software program. Execution of the instructions causes the processor 310 to perform the operations described herein. For example, the processor 310 receives IPP measurement output data transmitted from the pressure sensor 306. The processor 310 may ensure that the received IPP output data conforms to a specified range. Additionally, the processor 310 may make adjustments to the output data based on patient information and / or force sensor information.

[0068] The operations performed by the processor 310 provide for the determination of a fill volume parameter for PD therapy. In some embodiments, the processor 310 uses the received data to calculate or otherwise determine a fill volume parameter for the patient under measurement. Additionally or alternatively, the processor 310 may cause a display device to display the IPP measurement and / or adjustment value information, allowing a clinician to determine a fill volume parameter for the patient's PD therapy.

[0069] Figure 4 is a schematic diagram of another embodiment of an IPP measurement system 300. In the illustrated example of Figure 4, the pump 304 is replaced by positioning the fluid container 302 at or above the patient's head height (e.g., 3-6 feet above ground level). This allows gravity to draw the PD fluid from the fluid container 302, through the transfer set 102, and into the patient's abdominal cavity 106. In the illustrated example, a clamp 110 provides selective flow of the PD fluid.

[0070] Additionally, FIG. 4 also shows that a portable device 402 is communicatively coupled to the pressure sensor 306. The connection may be via a wired interface, such as a USB connection, or a wireless interface, such as Bluetooth, Zigbee, or NFC. The portable device 402 may include a smartphone, tablet computer, laptop computer, or the like. In some instances, the portable device 402 is communicatively coupled to a server or the processor 310 of FIG. 3 via a local area connection, such as the internet or Wi-Fi. The portable device 402 is configured to receive IPP output data from the pressure sensor 306 to determine a fill volume parameter for the patient. Similar to the processor 310 of FIG. 3, the portable device 402 enables adjustments to be made to the IPP measurement and / or the fill volume parameter based on the force sensor output data and / or patient information.

[0071] 5-7 are schematic diagrams of the pressure sensor 306 of FIGS. 3 and 4 according to exemplary embodiments of the present disclosure. In the illustrated embodiment, the pressure sensor includes an amplifier. A typical IPP value is 15-20 centimeters of water ("cmH2O") (0.213-0.284 pounds per square inch ("psig"). However, many commercially available pressure sensors for medical applications have a pressure range of 0.0-5.0 psig. As a result, using a commercially available pressure sensor to measure IPP may use only a small portion of the range at the low end of the detectable pressure. Many known pressure sensors are not very accurate below 0.8 psig and may not adequately have measurement precision over a pressure range of 0.2-0.3 psig. The disclosed amplifier extends the measurement range, thereby enabling the pressure sensor 306 to provide more accurate discrimination between IPP measurements.

[0072] 5 shows a pressure sensor 306 adapted to contact the transfer set 102. In other cases, the pressure sensor 306 may be connected to or integrated with the catheter 104. The pressure sensor 306 includes a pressure element 502 that converts the measured pressure into a digital and / or analog signal. The pressure element 502 includes at least one of a piezoresistive strain gauge, a pressure-sensing diaphragm, a pressure pod, a capacitive diaphragm, a pressure-sensing capsule, or a Bourdon tube.

[0073] The pressure sensor 306 also includes an amplifier 504. The amplifier 504 includes a first side that contacts a portion of the transferset 102. A second, opposite side of the amplifier 504 contacts the pressure element 502. The first side of the amplifier 504 has a larger diameter or surface area compared to the second side that contacts the pressure element 502. The force differential is illustrated in FIG. 5 by pistons, with the first piston having a greater surface area than the second piston. The force applied from the transferset 502 to the first area causes the first piston to apply a force against the second piston. The force from the first piston is concentrated against the smaller surface area of ​​the second piston. This concentration of force increases the applied force value, which is sensed by the pressure element 502.

[0074] The pressure amplifier 504, in one embodiment, uses Pascal's Law to amplify the fluid pressure within the transferset 102. Pressure amplification allows medical grade pressure sensors to be used in this low IPP measurement application. According to Pascal's Law, force or pressure is proportional to the surface area over which the force is applied. In one example, a 2 cm 2 A force having a value of 1 psig applied to a first surface area of ​​1 cm 2 1. In the illustrated example, the first side of amplifier 504 has an area (A1) that is at least twice the area of ​​the second side (A2), thereby providing an amplification factor of at least 2. In other embodiments, the areas of the first and second sides may be selected to provide amplification factors of 3, 4, 5, 10, 20, and the like.

[0075] In the illustrated example, the processor 310 and / or the portable device 402 is configured to normalize the IPP measurement to account for the amplification. For example, if the amplification is provided by the amplifier 504, the processor 310 and / or the portable device 402 may scale the IPP measurement by an amplification factor. In other embodiments, a fill volume parameter may be correlated with the amplified IPP measurement.

[0076] FIG. 6 illustrates an alternative embodiment of the pressure sensor 306. In the illustrated embodiment, a section 602 of the transferset 102 includes a material having a higher elasticity compared to the other sections. The higher elasticity allows the section 602 to amplify the pressure exerted on the pressure element 502 as pressure increases within the transferset 102. Similar to the embodiment discussed in connection with FIG. 5, the embodiment of FIG. 6 provides an increased IPP measurement range, thereby improving the accuracy of IPP measurement detection. In some embodiments, the elastic expansion of the material of the section 602 is linear. If the material of the section 602 exhibits nonlinear expansion, the processor 310 and / or the portable device 402 are configured to account for the nonlinearity of the material. This consideration may include providing a nonlinear calibration curve for the section 602 that corresponds to a linear pressure change within the transferset 102.

[0077] FIG. 7 illustrates a further embodiment of a pressure sensor 306. In this example, at least a portion of the transferset 102 includes a dual lumen with a fluid path side 702 and a non-fluid path side 704. The dual lumen may extend through the transferset 102 or may be located in a section adjacent to the sensor element. The non-fluid path side 704 may be filled with air or fluid of a known volume and / or pressure, thereby providing a reference pressure. A diaphragm 706 separates the sides 702 and 704 of the transferset 102. The diaphragm 706 moves toward the fluid path side 702 when the reference side 704 has a higher pressure, and vice versa. A sensor element 710 may be positioned adjacent to the reference side 704. As the diaphragm 706 moves, the volume within the side 704 changes, thereby changing the internal pressure. The sensor element 710 senses this internal pressure, which is transmitted to the processor 310 and / or portable device 402 as an IPP measurement. II. Force Sensing Embodiments

[0078] 8 is a schematic diagram showing a force sensor 802 connected to or otherwise integrated with the pressure sensor 306 of FIGS. 3-7, according to an exemplary embodiment of the present disclosure. In some instances, the IPP measurements performed by the pressure sensor 306 may be inaccurate due to changes in the orientation of the patient or the sensor itself. Changes in orientation or position cause an increase or decrease in the IPP pressure reading due to changes in head height and / or stress exerted on the abdominal cavity.

[0079] To reduce IPP measurement errors, the example force sensor 802 provides force output data indicative of pressure sensor 306 and / or patient movement. The force output data is received by the processor 310 and / or portable device 402 to adjust the IPP measurements and / or fill volume parameters. In some cases, force values ​​above a certain threshold may cause the IPP measurements to be ignored by the processor 310 and / or portable device 402. For example, detection of a significant change in patient position may cause the processor 310 and / or portable device 402 to remove IPP measurements recorded during that movement, since the movement is likely to contribute significant error to the measurement.

[0080] The force sensor 802 may include an inertial sensor, a gyroscope, and / or an accelerometer. Sensing may be provided in at least one axis, including the x, y, z, yaw, pitch, and / or roll axes. In some embodiments, the force sensor 802 and / or the pressure sensor 306 are placed at the patient's midline (if supine) or on or in line with the pelvic cavity (if seated / standing). The force sensor 802 detects relative changes in the orientation / angle of the pressure sensor 306 and / or the patient from an initial placement position.

[0081] The force sensor 802 transmits the force output data to the processor 310 and / or the portable device 402. In some cases, the force sensor 802 may use the same transceiver or transmitter as the pressure sensor 306. In other cases, the force sensor 802 may have its own transceiver or transmitter. The processor 310 and / or the portable device 402 use the force output data to determine whether the IPP measurement should be processed and, if applicable, provide adjustments to the IPP measurement and / or fill volume parameters.

[0082] FIG. 9 is a flow diagram of an exemplary procedure 900 for determining a patient's fill volume parameter using force output data in conjunction with IPP measurements, according to an exemplary embodiment of the present disclosure. While procedure 900 is described with reference to the flow diagram illustrated in FIG. 9 , it should be understood that many other ways of performing the steps associated with procedure 900 may be used. For example, the order of many of the blocks may be changed, certain blocks may be combined with other blocks, and many of the described blocks may be optional. In an embodiment, the number of blocks may be changed. For example, force output data may be used to correct the fill volume parameter rather than the IPP measurement. The operations described in procedure 900 may be defined by one or more instructions and implemented among multiple devices, including, for example, force sensor 802, pressure sensor 306, processor 310, and / or portable device 402.

[0083] The exemplary procedure 900 begins when the patient is connected to the transfer set 102 and catheter 104. After the transfer set 102 is in place, the force sensor 802 is zeroed or reset while placed at the patient's midline or lower pelvis (block 902). Such a reset provides a zero point for the inertial sensors and / or accelerometers. In some cases, a clinician may manually zero the force sensor 802 by pressing a reset button on the sensor. Alternatively, the clinician may type an input into the processor 310 and / or portable device 402, which transmits a command to the force sensor 802 to zero or reset it.

[0084] The clinician then begins filling the patient's abdominal cavity. After a certain percentage of the cavity is filled, the flow of PD fluid is stopped and the pressure sensor 306 transmits IPP measurement data 903 indicating the IPP in the abdominal cavity (block 904). The processor 310 and / or portable device 402 receives force output data 905 from the force sensor 802 (block 906). The processor 310 and / or portable device 402 compares the force output data 905 to one or more force limit values ​​(block 908). If the force output data 905 exceeds one or more force limit values, the processor 310 and / or portable device 402 ignores the corresponding IPP measurement data 903 (block 910). Force output data that exceeds one or more limit values ​​may indicate a changing position of the patient, causing a greater amount of movement or dropping the pressure sensor 306 or transfer line 102. In these cases, the IPP measurement data may not be accurate or representative of the actual IPP pressure.

[0085] When the force output data is within one or more limits, the processor 310 and / or portable device 402 proceeds to process the IPP measurement data 903 (block 912). This includes determining the IPP measurement component attributable to the measured force (block 914). FIG. 10 is a diagram illustrating how the processor 310 and / or portable device 402 calculates the IPP component associated with patient and / or sensor movement, according to an exemplary embodiment of the present disclosure. In the illustrated example, the sensor 306, 802 may be moved to a different or more convenient location for the clinician or patient, such as either a higher or lower location. This may be due to the patient having a higher exit site for their catheter or to allow the sensor 306, 802 to be in a location that is most comfortable or convenient for the clinician / patient. The processor 310 and / or portable device 402 uses the raw force output data 1002 to calculate the change in position of the sensor 306, 802. A change in position provides, for example, a change in head height, which correlates to a change in pressure within the transfer set 102 based on the degree of change. Changes to lateral position and / or rotation also correspond to changes in pressure. The pressure change is summed as an IPP component (i.e., Δh) associated with the sensor 306, 802 and / or patient movement. As shown in FIG. 10, the processor 310 and / or portable device 402 adjusts the IPP measurement based on the IPP component associated with the force output data. This may include updating an adjustment value or subtraction based on the IPP component (block 916 of FIG. 9).

[0086] Returning to FIG. 9 , the processor 310 and / or portable device 402 then outputs or otherwise displays the adjusted IPP measurement 917 (block 918). In some cases, the steps of blocks 902-918 are repeated at least once to obtain a sample set of IPP measurements over one or more respiratory cycles, allowing the IPP measurements to be averaged. In some embodiments, the processor 310 and / or portable device 402 displays a graph showing the IPP measurements over time, thereby allowing the average to be calculated or otherwise determined. The processor 310 and / or portable device 402 then determines a fill volume parameter based on the adjusted IPP measurement (block 920). The fill volume may be determined by correlating the fill volume with IPP measurements for patients with a similar body mass / height to the patient under measurement. In other cases, the volume of PD fluid infused into the patient may be measured using either a flow sensor or by draining and measuring the PD fluid.

[0087] In some embodiments, if the IPP measurement falls below a threshold for performing an appropriate PD fill, additional PD fluid may be added to the patient. Steps 902-918 may be repeated until the adjusted IPP measurement is 16-19 cmH2O or 0.25-0.28 psig, indicating an appropriate fill volume for PD therapy. A fill volume parameter is then determined from patient characteristics and / or the detected amount of PD fluid infused into the patient's peritoneal cavity. The fill volume parameter may then be used for subsequent PD therapy, either using a PD machine for continuous ambulatory peritoneal dialysis ("CAPD") therapy or manually. The exemplary procedure 900 then ends.

[0088] In some embodiments, the patient may wear a force sensor. For example, the force sensor may be connected to the patient's wrist or abdomen. Output data from the sensor provides additional data indicative of patient movement. A force sensor worn by the patient may be used in conjunction with force sensor 802, which includes pressure sensor 306. Alternatively, only a force sensor connected to the patient is provided. In some cases, data from the force sensor connected to the patient is tracked over time in conjunction with IPP measurements. For example, the patient may go through a daily routine or set of activities with transfer set 102 connected. The IPP measurements may be correlated with the force data (allowing the force-related component to be removed) to identify the extent to which the IPP varies for the patient due to different orientations and / or activities. A clinician may use this correlation to ensure that the fill volume does not cause the patient's IPP to exceed clinically recommended limits, regardless of the position or activity performed by the patient, thereby improving patient comfort during treatment. The fill volume determined by the clinician may then be set within the patient's treatment or device prescription and downloaded locally or remotely to the patient's cycler or peritoneal dialysis machine. III. Example of IPP Measurement Demonstration

[0089] In some embodiments, the processor 310 and / or portable device 402 are configured to validate the IPP measurement data prior to processing the data. For example, as shown in block 908 of FIG. 9 , the processor 310 and / or portable device 402 compares the received IPP measurement data to one or more ranges or thresholds indicative of substantial patient and / or sensor movement. This operation may also include a comparison to one or more ranges and / or limits corresponding to normal fill pressures and / or expected IPP measurements. IPP measurements outside the ranges and / or limits may indicate problems with the catheter connection, catheter blockage, leaks in the transfer set, or other fluid connectivity issues.

[0090] 11 shows a graph 1100 illustrating a comparison of IPP measurements with one or more ranges and / or thresholds, according to an exemplary embodiment of the present disclosure. Graph 1100 includes a first range 1102 that corresponds to acceptable pressure measurements when PD fluid is being infused into a patient's abdominal cavity. During PD fluid fill, a force is applied to a sensor element (e.g., a transducer membrane) as a result of fluid flow. The first range 1102 may correlate to fluid fill for gravity-fed administration, while a second range may be used when a pump provides the PD fluid.

[0091] The graph 1100 also includes a second range 1104, which corresponds to reduced pressure as a result of partial occlusion of the transfer set or catheter. During the filling phase, the processor 310 and / or portable device 402 receives IPP measurement data and compares it to the first range 1102 and the second range 1104. If the IPP measurement data corresponds to the second range 1104, the processor 310 and / or portable device 402 may generate a warning or other message / indication that a problem with the catheter and / or transfer set exists. Additionally, the processor 310 and / or portable device 402 may prevent subsequent IPP measurements from being processed until it is confirmed that the patient is properly filled with PD fluid.

[0092] Graph 1100 shows a decrease in pressure measurement data over time. This decrease is a result of a lower flow rate as the gravity-fed PD fluid bag empties into the patient. In some instances, ranges 1102 and 1104 may have a corresponding decrease over time to account for the expected pressure decrease during PD fluid infusion. Pressure values ​​on the y-axis have been normalized for simplicity.

[0093] The graph 1100 also includes a third range 1106 that applies after the flow of PD fluid has been stopped and the fluid is allowed to dwell in the patient's abdominal cavity. The processor 310 and / or portable device 402 may use the third range 1106 to identify IPP measurements that exceed an acceptable pressure threshold, which may indicate patient movement, transfer set movement, or patient overfill. IPP measurements that exceed this third range 1106 may be ignored by the processor 310 and / or portable device 402. Additionally or alternatively, the processor 310 and / or portable device 402 may generate an alarm. Note that the IPP measurement increases over time because the PD fluid absorbs waste products or other toxins from the patient, which increases the volume of fluid in the abdominal cavity and thereby increases the measured pressure. The processor 310 and / or portable device 402 may be configured to log IPP measurements over time to ensure that the PD fill volume does not exceed the allowable IPP during the dwell phase, which may cause patient discomfort during PD treatment.

[0094] 12 shows a graph 1200 of an alternative embodiment in which the processor 310 and / or portable device 402 uses the recorded bag fill head height and bag solution volume to determine a threshold value 1202 corresponding to the expected fill pressure. If a pump is provided, the expected pump pressure value may be used instead. In this example, the processor 310 and / or portable device 402 estimates the threshold value based on the actual fill conditions to more accurately determine whether a problem exists infusing PD fluid into the patient's abdominal cavity. The graphs 1100 and 1200 may be displayed to the clinician by the processor 310 and / or portable device 402. IV. Embodiments of IPP Measurement Adjustment Using Patient Information

[0095] During IPP measurement, the processor 310 and / or portable device 402 may adjust the IPP measurement or fill volume parameters based on the received patient information. In some situations, the patient's fluid retention may affect the abdominal volume or pressure provided on the cavity, which affects the IPP measurement. In addition, the patient's blood pressure or heart rate may indicate whether the patient is under stress or exertion, which may also affect the IPP measurement.

[0096] 13 is a diagram 1300 illustrating data processing by the processor 310 and / or portable device 402 to adjust the IPP measurement based on patient information, according to an exemplary embodiment of the present disclosure. As shown, the processor 310 and / or portable device 402 receives IPP measurement data 903. The processor 310 and / or portable device 402 may also receive urine data 1302 indicating the patient's urine output within a specified time period prior to the IPP measurement, such as 24 or 48 hours. The urine output may be self-reported by the patient and entered into the processor 310 and / or portable device 402. In other cases, the urine output may be measured in a container and entered into the processor 310 and / or portable device 402.

[0097] The processor 310 and / or portable device 402 also receive food and beverage consumption information 1304. This information provides an indication of the amount of food and beverage consumed by the patient in the period leading up to or between IPP measurements. Together, the urine data 1302 and the food / drink data 1304 provide fluid balance information. The processor 310 and / or portable device 402 is configured to calculate the patient's fluid balance by summing the food / drink data 1304, subtracting the urine data 1302, and considering metabolic combustion of fluids based on a patient population of similar age, sex, height, and weight. The processor 310 and / or portable device 402 then determines whether the patient's fluid balance provides an IPP measurement component by comparing the calculated balance information with correlations of balance information and IPP measurements for patients with similar height, sex, weight, etc. The processor 310 and / or portable device 402 then adjusts the IPP measurement data 903 by taking into account the IPP component associated with the fluid balance state. In instances where the fluid balance state is negative, such as in instances of dehydration, the adjustment may result in an increase in the value of the IPP measurement.

[0098] The processor 310 and / or portable device 402 also receives heart rate and blood pressure data 1306. The processor 310 and / or portable device 402 correlates the data 1306 with IPP measurement components based on a population of patients with similar height, weight, sex, age, etc. The processor 310 and / or portable device 402 then adjusts the IPP measurement by the identified IPP measurement components.

[0099] After adjusting the IPP measurement, the processor 310 and / or portable device 402 determines a fill volume parameter 917. As discussed above, this may include comparing the adjusted IPP measurement (or the trend of the adjusted IPP measurement) to a fill IPP limit for PD therapy. Once the IPP measurement is complete but the limit has not been exceeded, the processor 310 and / or portable device 402 determines the fill volume as the volume of PD fluid in the patient's abdominal cavity using either the patient's body mass or determining the PD fluid volume by draining the fluid and / or using a flow sensor. The fill volume parameter 917 may then be used for subsequent PD therapy. V. Lung Volume Embodiments for Determining Filling Volume

[0100] In the examples discussed above, IPP measurements are made using pressure sensor 306. In some embodiments, pressure sensor 306 may be replaced with a lung volume sensor, such as a spirometer. Lung volume has been shown to decrease as IPP increases. Processor 310 and / or portable device 402 may use the known correlation between lung volume and IPP measurements to determine a filling volume parameter for the patient without the use of a pressure sensor.

[0101] 14 shows an exemplary system 1400 in which a spirometer 1402 is used to perform lung volume measurements and determine filling volume parameters, according to an exemplary embodiment of the present disclosure. Such lung volume measurements allow for greater efficiency for IPP measurements, which may otherwise result in the errors discussed above. Furthermore, the use of a spirometer 1402 allows for a standard transfer set and catheter to be used, as opposed to a transfer set or catheter equipped with a pressure sensor.

[0102] 14, spirometer 1402 measures patient breathing volume at different filling levels, designated as M0 (dry), M1 (10% of filling capacity), M2 (20% of filling capacity), M3 (50% of filling capacity), etc. After the patient is filled to an estimated desired percentage of cavity volume, spirometer 1402 records the patient's lung volume. Spirometer 1402 may record lung volume over one or more respiratory cycles to determine an average lung volume.

[0103] The exemplary processor 310 and / or portable device 402 receives lung volume data from the spirometer 1402. The processor 310 and / or portable device 402 uses the known correlation between lung volume and IPP to adjust the IPP measurement to provide a more accurate measurement. The identified IPP value may then be used to determine a fill volume and / or identify when the PD fluid reaches a desired percentage of capacity to be effective for PD therapy. This fill volume is stored by the processor 310 and / or portable device 402 as a fill volume parameter for use in PD therapy for the patient.

[0104] A patient-specific correlation between fill volume and lung volume can be determined and subsequently used for PD therapy. In these embodiments, a PD machine may use periodic lung volume measurements to estimate a patient's IPP or fill volume during different phases of PD therapy. FIG. 15 shows a graph 1500 of a patient-specific correlation between lung volume and fill volume, according to an exemplary embodiment of the present disclosure. Graph 1500 shows that as PD fill volume increases, lung volume decreases. Such a correlation may be useful in PD therapy, where lung volume measurements may be used to attempt to estimate a patient's IPP or in lieu of directly measuring it. VI. conclusion

[0105] It should be understood that various changes and modifications to the presently preferred embodiments described herein will be apparent to those skilled in the art. Such changes and modifications can be made without departing from the spirit and scope of the present subject matter and without diminishing its intended advantages. It is therefore intended that such changes and modifications be covered by the appended claims.

Claims

1. 1. An intraperitoneal pressure ("IPP") measurement system comprising: a fluid container for containing a peritoneal dialysis ("PD") fluid; a transfer set and catheter in fluid communication with the fluid container and in fluid communication with a patient's abdominal cavity configured to enable PD fluid to be provided to the patient's abdominal cavity; a pressure sensor configured to contact the transfer set or the catheter, the pressure sensor configured to transmit output data indicative of an IPP within the patient's abdominal cavity, the pressure sensor comprising: a pressure element configured to measure a pressure exerted by a fluid in the transfer set or catheter; a pressure amplifier having a first side contacting a portion of the transfer set or catheter and a second side contacting the pressure element, the first side having a larger diameter or surface area compared to the first side; A pressure sensor including: A processor communicatively coupled to the pressure sensor, the processor comprising: receiving the output data indicative of the IPP within the patient's abdominal cavity; receiving patient information including force data indicative of at least one of patient movement or pressure sensor movement, spirometry data indicative of the patient's lung capacity, or at least one of urine output within a defined period of time, food / drink intake within a defined period of time, heart rate, or blood pressure; adjusting the output data indicative of the IPP using the force data, the spirometry data, or the patient information; at least one of using the adjusted output data indicative of the IPP to determine a fill volume parameter related to a PD treatment for the patient, or displaying the adjusted output data indicative of the IPP to enable determination of the fill volume parameter; a processor configured to: A system comprising:

2. The system of claim 1 , wherein the first side includes a diameter or surface area that is at least twice the diameter or surface area of ​​the second side to provide pressure amplification by at least a factor of two.

3. The system of claim 1 , wherein the pressure element comprises at least one of a piezoresistive strain gauge, a pressure sensitive diaphragm, a capacitive diaphragm, a pressure sensitive capsule, or a Bourdon tube.

4. The system of claim 1 , wherein the pressure sensor is integrally formed with the transfer set or catheter.

5. The system of claim 1 , wherein the pressure sensor is mechanically connected to the transfer set or catheter.

6. 2. The system of claim 1, wherein the output data indicative of the IPP in the patient's peritoneal cavity corresponds to a pressure measurement made by the pressure sensor during a dwell interval between when the PD fluid is provided to and removed from the patient's peritoneal cavity.

7. The system of claim 1 or 6, wherein the fluid container is placed at head height, and the system further includes a line clamp that, when closed, occludes the flow of the PD fluid through the transfer set or catheter.

8. 10. The system of claim 1 or 6, further comprising a pump configured, when activated, to move the PD fluid from the fluid container through the transfer set and catheter to the patient's abdominal cavity.

9. 10. The system of claim 1, 6, or 8, further comprising an automated peritoneal dialysis ("APD") machine configured to provide the PD therapy for the patient using at least the fill volume parameter.

10. a force sensor included with the pressure sensor or adapted to contact the transfer set or catheter, the force sensor including at least one of an inertial sensor, a gyroscope, or an accelerometer for sensing at least one of linear or rotational acceleration in one or more axes; The system of claim 1 , 6, 8, or 9, wherein the force sensor is configured to output the force data.

11. 11. The system of claim 10, wherein the processor is further configured to receive the force data and use the force data to adjust the output data indicative of the IPP to account for measurement components related to at least one of patient movement or pressure sensor movement.

12. The processor further comprises: comparing the output data indicative of the IPP with at least one data range; providing an indication that a problem exists with at least one of the transfer set or the catheter when the comparison falls outside the at least one data range; and determining said fill volume parameter using said output data indicative of said IPP when said comparison is within said at least one data range; The system of claim 1 or 11, configured to:

13. The processor further comprises: receiving second output data from the pressure sensor indicative of a pressure during filling of the patient's abdominal cavity with an increasing amount of the PD fluid; comparing the second output data indicative of the pressure during filling of the patient's abdominal cavity to a second data range; providing an indication that a problem exists with at least one of the transfer set or the catheter when the comparison falls outside the second data range; and when the comparison is within the second data range, using the output data indicative of the IPP to determine the fill volume parameter; The system of claim 12 configured to:

14. 2. The system of claim 1, wherein the defined period of time comprises at least one of 24 hours or 48 hours prior to causing the pressure sensor to provide the output data indicative of the patient's IPP.

15. The system of claim 1, further comprising a spirometer for transmitting the spirometry data.